Literature DB >> 25772753

Different socioeconomic inequalities exist in terms of the prevention, diagnosis and control of diabetes.

Hoo-Yeon Lee1, Myung-Il Hahm2, Kui Son Choi3, Jae Kwan Jun3, Mina Suh3, Chung Mo Nam4, Eun-Cheol Park5.   

Abstract

OBJECTIVE: To evaluate socioeconomic disadvantage in prevalence, awareness and control of diabetes in universal coverage healthcare system.
METHODS: Data from the fifth KNHNES (2010-12) were analyzed. The sample included 10,208 individuals with diabetes aged ≥30 years. Diabetes was defined by (i) a self-reported previous diagnosis of diabetes made by a physician, (ii) the current use of oral hypoglycaemic agents and/or insulin or (iii) fasting plasma glucose ≥126 mg/dl. Subjects who were first diagnosed by the survey were classified as 'undiagnosed'. Inadequate control was defined as HbA1c ≥6.5%.
RESULTS: It was estimated that 26.4% of subjects with diabetes were not aware of their condition and 73.1% of cases of diabetes were not adequately controlled. Inequalities in socioeconomic status were related to the diabetes prevalence in both men and women. Educational level was not predictive of diagnosis or control in men or women, whereas lower household income level was associated with diagnosis in men only.
CONCLUSIONS: This widespread lack of awareness and inadequate control underscore the need for intensive efforts in these domains. Monitoring is expected to highlight the gaps in the preventive and care services offered to the most vulnerable individuals and it may induce governments and practitioners to address these issues.
© The Author 2015. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25772753     DOI: 10.1093/eurpub/ckv021

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  7 in total

1.  Association of Socio-Environmental Determinants with Diabetes Prevalence in the Athens Metropolitan Area, Greece: A Spatial Analysis.

Authors:  Antigoni Faka; Christos Chalkias; Diego Montano; Ekavi N Georgousopoulou; Anestis Tripitsidis; Efi Koloverou; Dimitris Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  Rev Diabet Stud       Date:  2018-03-10

2.  Socioeconomic Disparities in the Prevalence, Diagnosis, and Control of Hypertension in the Context of a Universal Health Insurance System.

Authors:  Hoo Yeon Lee
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

3.  Detection and Management of Diabetes in England: Results from the Health Survey for England.

Authors:  Mimi Xiao; Ciaran O'Neill
Journal:  Diabetes Ther       Date:  2017-09-25       Impact factor: 2.945

4.  Comparison of Health Status in Primary Care Underserved Area Residents and the General Population in Korea.

Authors:  Min So Kim; Kyae Hyung Kim; Sang Min Park; Jong-Goo Lee; Yeon Seo Ko; A Ra Cho; Yoon Su Ku
Journal:  Korean J Fam Med       Date:  2019-12-19

5.  Prioritizing Community-Based Intervention Programs for Improving Treatment Compliance of Patients with Chronic Diseases: Applying an Analytic Hierarchy Process.

Authors:  Do Hwa Byun; Rho Soon Chang; Myung-Bae Park; Hyo-Rim Son; Chun-Bae Kim
Journal:  Int J Environ Res Public Health       Date:  2021-01-08       Impact factor: 3.390

6.  Self-determination theory interventions versus usual care in people with diabetes: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Anne Sophie Mathiesen; Mette Juel Rothmann; Vibeke Zoffmann; Janus Christian Jakobsen; Christian Gluud; Jane Lindschou; Mette Due-Christensen; Bodil Rasmussen; Emilie Marqvorsen; Thordis Thomsen
Journal:  Syst Rev       Date:  2021-01-07

7.  Social Determinants of Health Associated with the Use of Screenings for Hypertension, Hypercholesterolemia, and Hyperglycemia among American Adults.

Authors:  Tran Nguyen; Amanda Barefield; Gia-Thien Nguyen
Journal:  Med Sci (Basel)       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.